Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-003461
Filing Date
2025-04-10
Accepted
2025-04-10 06:01:08
Documents
9

Document Format Files

Seq Description Document Type Size
1 forms-3a.htm S-3/A 343914
2 ex1-2.htm EX-1.2 210145
3 ex5-1.htm EX-5.1 43724
4 ex23-1.htm EX-23.1 3032
5 ex107.htm EX-FILING FEES 39777
6 forms3_001.jpg GRAPHIC 6338
7 ex5-1_001.jpg GRAPHIC 5937
8 ex5-1_002.jpg GRAPHIC 16264
9 ex5-1_003.jpg GRAPHIC 5642
  Complete submission text file 0001641172-25-003461.txt   689347
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-280721 | Film No.: 25826357
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)